Position in XENE
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$241,440
-$2,790 QoQ
Shares Held
4,000
-4.8% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in XENE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FNY Investment Advisers, LLC holds $6,470,178 across 59 Biotechnology names. XENE ranks #8 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
7,605 | $1,013,442 | |
| 2 | SGMT |
Sagimet Biosciences Inc.
|
109,250 | $844,502 | |
| 3 | 5,000 | $663,650 | |||
| 4 | JANX |
Janux Therapeutics, Inc.
|
30,850 | $473,856 | |
| 5 | NKTR |
Nektar Therapeutics
|
5,500 | $383,955 | |
| 6 | VERU |
Veru Inc.
|
105,081 | $328,903 | |
| 7 | VKTX |
Viking Therapeutics, Inc.
|
8,170 | $318,711 | |
| 8 | XENE |
Xenon Pharmaceuticals Inc.
This page
|
4,000 | $241,440 |
All Filings in XENE
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $241,440 | 4,000 | Shares | Defined | 2026-07-08 | |
| 2026-03-31 | $244,230 | 4,200 | Shares | Sole | 2026-04-15 | |
| No filing history on record for this holder in this stock. | ||||||